José Manuel García Aznar

November 7, 2023

Two members of the IIS Aragón are part of the team studying a new line of research against cancer

Pedro Baptista and Julián Pardo are the members of IIS Aragón who will work on this new line of research to unravel the mechanisms that reduce the effectiveness of CAR-T cell therapy.